TY -的T1与ferr口服补铁ic maltol in patients with pulmonary hypertension JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00616-2020 VL - 56 IS - 5 SP - 2000616 AU - Olsson, Karen M. AU - Fuge, Jan AU - Brod, Torben AU - Kamp, Jan C. AU - Schmitto, Jan AU - Kempf, Tibor AU - Bauersachs, Johann AU - Hoeper, Marius M. Y1 - 2020/11/01 UR - //www.qdcxjkg.com/content/56/5/2000616.abstract N2 - Iron deficiency is common in patients with pulmonary hypertension [1, 2]. The underlying pathomechanisms are complex and include impaired iron absorption, elevated hepcidin levels, augmented gastrointestinal loss and reduced availability from the reticuloendothelial system [1, 3, 4]. In patients with pulmonary hypertension, iron deficiency is associated with aggravated symptoms and an increased mortality risk [3, 5].Oral ferric maltol was well tolerated and effective in patients with pulmonary hypertension and iron deficiency anaemia. Restoration of iron stores corrected anaemia and resulted in improved right ventricular function and exercise tolerance https://bit.ly/2zMwvxcWe are indebted to the team of the Hannover Clinical Trial Center for providing logistic support throughout the study. ER -